Optum Rx Takes Additional Steps to Lower the Cost of Insulin
Beginning Jan. 1, 2024, Optum Rx will place eight preferred insulin products on tier one of standard commercial formularies, limiting out-of-pocket spend to $35 or less Action is part of ongoing...